Phase 3 Clinical Trial Evaluating Continu... - Cure Parkinson's
Phase 3 Clinical Trial Evaluating Continuous Subcutaneous Carbidopa/Levodopa (ND0612) Initiated In The United States For Parkinson's Disease
![Farooqji profile image](https://images.hu-production.be/avatars/d2bcede6695608a9d172b4c00f6b376c_small@2x_100x100.jpg)
Written by
![Farooqji profile image](https://images.hu-production.be/avatars/d2bcede6695608a9d172b4c00f6b376c_small@2x_100x100.jpg)
Farooqji
To view profiles and participate in discussions please or .
Read more about...
2 Replies
•
ND0612 update:
Phase 3 Trial of Investigational Parkinson Treatment ND0612 Initiated. Subcutaneous levodopa.
Not what you're looking for?
You may also like...
Bilateral Pallidothalamic Tractotomy (PTT) Clinical Trials in the United States
need/want treatment on one side from participating....